Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 2,686 | 2,460 | 2,685 |
| Cost of Goods | 362 | 303 | 297 |
| Gross Profit | 2,324 | 2,157 | 2,388 |
| Operating Expenses | 9,843 | 9,125 | 6,057 |
| Operating Income | -7,157 | -6,665 | -3,372 |
| Interest Expense | 405 | 479 | 2,641 |
| Other Income | -680 | -7,483 | 1,233 |
| Pre-tax Income | -8,242 | -14,627 | -4,780 |
| Net Income Continuous | -8,242 | -14,627 | -4,780 |
| Net Income | $-8,242 | $-14,627 | $-4,780 |
| EPS Basic Total Ops | -1.22 | -4.50 | -2.77 |
| EPS Basic Continuous Ops | -1.19 | -4.50 | -2.39 |
| EPS Diluted Total Ops | -1.22 | -4.50 | -2.77 |
| EPS Diluted Continuous Ops | -1.19 | -4.50 | -2.39 |
| EPS Diluted Before Non-Recurring Items | -1.22 | -3.38 | -2.77 |
| EBITDA(a) | $-6,993 | $-1,742 | $-3,236 |